Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2001, p. 754-757, Vol. 39, No. 2
Department of Pathology and Laboratory
Medicine, University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania 19104-4283
Received 11 August 2000/Returned for modification 16 October
2000/Accepted 10 November 2000
The Agilent 2100 bioanalyzer (Agilent Technologies, Palo Alto,
Calif.) utilizes capillary electrophoresis on a microchip device (LabChip 7500; Caliper Technologies, Mountain View, Calif.) that is
capable of rapidly sizing small DNA fragments. To determine whether the
system could replace conventional restriction fragment length
polymorphism (RFLP) typing by agarose gel electrophoresis, we compared
the analyzer with conventional flagellin RFLP for typing
Campylobacter jejuni. Ninety-seven isolates representing 46 Fla types were initially analyzed. Correct Fla types were detected in
59% of the isolates. The major problem with the system was in
resolving samples containing multiple DNA fragments differing from 8 to
20 bp. Overall, the bioanalyzer has the potential to replace
conventional RFLP analysis by gel electrophoresis, but improvements in
the chip separation are needed.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.754-757.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Agilent 2100 Bioanalyzer for Restriction Fragment Length
Polymorphism Analysis of the Campylobacter jejuni
Flagellin Gene
*
Corresponding author. Mailing address: University of
Pennsylvania, Department of Pathology & Laboratory Medicine, 4th Floor, Gates Building, 3400 Spruce St., Philadelphia, PA 19104-4283. Phone:
(215) 662-6651. Fax: (215) 662-6655. E-mail:
nachamki{at}mail.med.upenn.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»